Antibodies to HTLV-1/11 were investigated in sera from 7521 individual
s living in Spain. They were classified in four major groups: a) subje
cts at high risk of retroviral infections e.g. parenteral drug addicts
, homosexuals, prostitutes, and multiple-transfused individuals; b) pa
tients suffering illness associated with HTLV-I in endemic regions; c)
immigrants from endemic areas; and d) blood donors. Sera were collect
ed from 1984 to December 1991. Repeatedly reactive ELISA was found in
211 samples (2.8%), but Western blot only confirmed the presence of HT
LV-I/II antibodies in 23 samples (0.30%), corresponding to eight (0.25
%) out of 3207 drug abusers, six (0.72%) out of 894 immigrants (five A
fricans and one South American), three (0.41%) out of 727 patients wit
h HTLV-related diseases (one woman with HTLV-I associated myelopathy h
ad received blood transfusions in an endemic area), four (0.54%) out o
f 793 prostitutes, one multiple-transfused native woman, and one (0.16
%) out of 603 native seamen. The Western blot antibody pattern confirm
ed HTLV-II infection instead of HTLV-I in nine (39%) subjects. The rem
aining 14 (61%) HTLV-reactive samples were interpreted as HTLV-I serop
ositive, most of which were from immigrants. None of 857 blood donors
analysed was reactive for HTLV antibody. These results suggest that bo
th HTLV-I and HTLV-II are present in Spain, although at a low rate and
mostly restricted to individuals coming from endemic areas, drug addi
cts, and prostitutes. Furthermore, diseases related to HTLV-I (particu
larly lymphoproliferative disorders, and subacute myelopathies) seem t
o be rarely associated with these viruses in Spain, a non-endemic area
.